A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

SPECIAL REPORT

HIV / AIDS

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Viral Infections, Non-HIV

Persisting Antibody Response Nine Years after Bivalent HPV Vaccination in A Cohort of Dutch Women: Immune Response and the Relation with Genital HPV Infections

J Infect Dis.

Hoes J, Pasmans H, Knol MJ, Donken R, van Marm-Wattimena N, Schepp RM, King AJ, van der Klis FRM, de Melker HE

doi: 10.1093/infdis/jiaa007.

Viral Infections, Non-HIV

Missing Cases of Herpes simplex virus (HSV) Infection of the Central Nervous System Applying Reller Criteria for HSV PCR testing: A Multicenter Study

Vaccine.

Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group

doi: 10.1016/j.vaccine.

Viral Infections, Non-HIV

Immune response to influenza vaccination in the elderly is altered by chronic medication use

Immun Ageing.

Agarwal D, Schmader KE, Kossenkov AV, Doyle S, Kurupati R, Ertl HCJ

doi: 10.1186/s12979-018-0124-9.

Viral Infections, Non-HIV

Persistence of varicella-zoster virus cell-mediated immunity after the administration of a second dose of live herpes zoster vaccine

J Infect Dis.

Weinberg A, Popmihajlov Z, Schmader KE, Johnson MJ, Caldas Y, Salazar AT, Canniff J, McCarson BJ, Martin J, Pang L, Levin MJ

doi: 10.1093/infdis/jiy514.

Viral Infections, Non-HIV

Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance

PLoS Pathog.

Rosenberg BR, Depla M, Freije CA, Gaucher D, Mazouz S, Boisvert M, Bédard N, Bruneau J, Rice CM, Shoukry NH

doi: 10.1371/

Viral Infections, Non-HIV

Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children

Pediatr Infect Dis J.

Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres F, Pollard AJ, Růžková R, Martinez AC, Ulied A, Valdivieso MM, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK

doi: 10.1097/INF.

Viral Infections, Non-HIV

A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

Vaccine.

van de Witte S, Nauta J, Montomoli E, Weckx J

doi: 10.1016/

Related content

11e Conférence de la Société internationale sur le SIDA (IAS) 2021

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Persisting Antibody Response Nine Years after Bivalent HPV Vaccination in A Cohort of Dutch Women: Immune Response and the Relation with Genital HPV Infections

Missing Cases of Herpes simplex virus (HSV) Infection of the Central Nervous System Applying Reller Criteria for HSV PCR testing: A Multicenter Study

Immune response to influenza vaccination in the elderly is altered by chronic medication use

Persistence of varicella-zoster virus cell-mediated immunity after the administration of a second dose of live herpes zoster vaccine

Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance

Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children

A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021